BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2011

View Archived Issues

New cannabinoid CB2 receptor agonists discovered

Read More

AstraZeneca patents new diacylglycerol O-acyltransferase 1 inhibitors

Read More

New melanin-concentrating hormone MCH1 receptor antagonists disclosed

Read More

Merck & Co. claims novel gamma-secretase modulators

Read More

Chimerix begins enrollment in open-label study of CMX-001

Read More

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

Read More

PC-1005 gel protects monkeys from infection with simian HIV

Read More

Studies examine pharmacodynamics and antidepressant efficacy of LY-2216684

Read More

Zydus-Cadila discloses new GPR119 receptor agonists

Read More

Immutep and GSK enter into agreement for ImmuTune IMP-731

Read More

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Read More

Isis expands pipeline with ISIS-STAT3Rx and ISIS-FGFR4Rx

Read More

NPS Pharma concludes treatment in phase III STEPS trial of Gattex

Read More

CeNeRx BioPharma begins phase II trial of modified-release CX-157

Read More

Daiichi Sankyo launches Cravit intravenous injections in Japan

Read More

MacroGenics begins phase I study of MGAH-22 in HER2-positive tumors

Read More

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Read More

Phase III trial begins for lubiprostone in opioid-induced bowel dysfunction

Read More

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Read More

New unbiased approach described for discovery of IgG biomarkers with diagnostic potential

Read More

Esperion begins phase II trial of ETC-1002 in lipid regulation

Read More

Phase II data reported on LCP-Tacro in de novo liver transplant recipients

Read More

Dara BioSciences presents additional data from phase I DB-959 trial

Read More

EffRx Pharma submits NDA to FDA for EX-101

Read More

FDA grants marketing approval for diaDexus' automated PLAC test

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing